Hereditary neuropathies.
OBJECTIVE
The purpose of this review is to help neurologists understand new concepts in hereditary neuropathies, from the clinician's point of view, in the molecular era after the burst of information regarding peripheral nerve biology.


RESULTS
Recent studies have focused on understanding the pathomechanisms involved in hereditary neuropathies. In the past year identification of new genes has slowed down since scientists have concentrated more on the function of genes causing Charcot-Marie-Tooth disease and Schwann cell-axon interactions to reveal the molecular cell biology of the disease. Animal models for the most common subtypes of human Charcot-Marie-Tooth disease are now available.


CONCLUSIONS
Rapid advances in the molecular genetics and cell biology of hereditary neuropathies have highlighted the great genetic complexity of Charcot-Marie-Tooth disease. The evolution from a simple clinical classification to a complex molecular one has not facilitated our understanding of the disease. Moreover, the new molecular classification is not simple to use as different mutations of the same gene produce a range of phenotypes. The clinicians have to look for specific clinical and electrophysiological clues to direct the patient to appropriate genetic testing.
Parman
Yesim
Y
Istanbul Faculty of Medicine, Neurology Department, Istanbul University, Istanbul, Turkey. parmany@istanbul.edu.tr
D000818:Animals; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D004568:Electrodiagnosis; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing / Q000592:standards; D015417:Hereditary Sensory and Motor Neuropathy / Q000235:genetics* / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D009154:Mutation / Q000235:genetics; D010525:Peripheral Nerves / Q000276:immunology* / Q000503:physiopathology